Literature DB >> 28028310

Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Jan Felix1,2,3, Savvas N Savvides1,2.   

Abstract

Immune responses are regulated by effector cytokines and chemokines that signal through cell surface receptors. Mammalian decoy receptors - which are typically soluble or inactive versions of cell surface receptors or soluble protein modules termed binding proteins - modulate and antagonize signalling by canonical effector-receptor complexes. Viruses have developed a diverse array of molecular decoys to evade host immune responses; these include viral homologues of host cytokines, chemokines and chemokine receptors; variants of host receptors with new functions; and novel decoy receptors that do not have host counterparts. Over the past decade, the number of known mammalian and viral decoy receptors has increased considerably, yet a comprehensive curation of the corresponding structure-mechanism relationships has not been carried out. In this Review, we provide a comprehensive resource on this topic with a view to better understanding the roles and evolutionary relationships of mammalian and viral decoy receptors, and the opportunities for leveraging their therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28028310     DOI: 10.1038/nri.2016.134

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  200 in total

1.  Structures of the extracellular domain of the type I tumor necrosis factor receptor.

Authors:  J H Naismith; T Q Devine; T Kohno; S R Sprang
Journal:  Structure       Date:  1996-11-15       Impact factor: 5.006

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 3.  Ectodomain shedding and ADAMs in development.

Authors:  Silvio Weber; Paul Saftig
Journal:  Development       Date:  2012-10       Impact factor: 6.868

Review 4.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

5.  Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.

Authors:  Wangko Lundström; Steven Highfill; Scott T R Walsh; Stephanie Beq; Elizabeth Morse; Ingrid Kockum; Lars Alfredsson; Tomas Olsson; Jan Hillert; Crystal L Mackall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

Review 6.  TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.

Authors:  Cecilia Garlanda; Hans-Joachim Anders; Alberto Mantovani
Journal:  Trends Immunol       Date:  2009-08-21       Impact factor: 16.687

7.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

8.  Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.

Authors:  K Mossman; C Upton; R M Buller; G McFadden
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

9.  Structural basis of IL-23 antagonism by an Alphabody protein scaffold.

Authors:  Johan Desmet; Kenneth Verstraete; Yehudi Bloch; Eric Lorent; Yurong Wen; Bart Devreese; Karen Vandenbroucke; Stefan Loverix; Thore Hettmann; Sabrina Deroo; Klaartje Somers; Paula Henderikx; Ignace Lasters; Savvas N Savvides
Journal:  Nat Commun       Date:  2014-10-30       Impact factor: 14.919

10.  Crystal structure of TNFalpha complexed with a poxvirus MHC-related TNF binding protein.

Authors:  Zhiru Yang; Anthony P West; Pamela J Bjorkman
Journal:  Nat Struct Mol Biol       Date:  2009-10-18       Impact factor: 15.369

View more
  26 in total

1.  IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation.

Authors:  Aurora Holgado; Harald Braun; Elien Van Nuffel; Sammy Detry; Martijn J Schuijs; Kim Deswarte; Karl Vergote; Mira Haegman; Griet Baudelet; Jurgen Haustraete; Hamida Hammad; Bart N Lambrecht; Savvas N Savvides; Inna S Afonina; Rudi Beyaert
Journal:  J Allergy Clin Immunol       Date:  2019-03-13       Impact factor: 10.793

2.  Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor.

Authors:  Sami Abdulkadir; Chunpu Li; Wei Jiang; Xue Zhao; Peng Sang; Lulu Wei; Yong Hu; Qi Li; Jianfeng Cai
Journal:  J Am Chem Soc       Date:  2021-12-30       Impact factor: 15.419

3.  Environmental exposures are hidden modifiers of anti-viral immunity.

Authors:  Anthony M Franchini; B Paige Lawrence
Journal:  Curr Opin Toxicol       Date:  2018-01-31

4.  Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus.

Authors:  Haleh Heidarieh; Antonio Alcamí
Journal:  J Biol Chem       Date:  2018-09-26       Impact factor: 5.157

5.  Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity.

Authors:  Sam Detry; Julie Andries; Yehudi Bloch; Cem Gabay; Danielle M Clancy; Savvas N Savvides
Journal:  J Biol Chem       Date:  2022-04-06       Impact factor: 5.486

6.  Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma.

Authors:  Kenneth Verstraete; Frank Peelman; Harald Braun; Juan Lopez; Dries Van Rompaey; Ann Dansercoer; Isabel Vandenberghe; Kris Pauwels; Jan Tavernier; Bart N Lambrecht; Hamida Hammad; Hans De Winter; Rudi Beyaert; Guy Lippens; Savvas N Savvides
Journal:  Nat Commun       Date:  2017-04-03       Impact factor: 14.919

7.  The in Vitro Inhibitory Effect of Ectromelia Virus Infection on Innate and Adaptive Immune Properties of GM-CSF-Derived Bone Marrow Cells Is Mouse Strain-Independent.

Authors:  Lidia Szulc-Dąbrowska; Justyna Struzik; Joanna Cymerys; Anna Winnicka; Zuzanna Nowak; Felix N Toka; Małgorzata Gieryńska
Journal:  Front Microbiol       Date:  2017-12-19       Impact factor: 5.640

8.  Virtual screening for inhibitors of the human TSLP:TSLPR interaction.

Authors:  Dries Van Rompaey; Kenneth Verstraete; Frank Peelman; Savvas N Savvides; Koen Augustyns; Pieter Van Der Veken; Hans De Winter
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

Review 9.  The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome.

Authors:  Carlene Petes; Natalya Odoardi; Katrina Gee
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

10.  Natural Immunomodulators.

Authors:  D Ortuño-Sahagún; K Zänker; A K S Rawat; S V Kaveri; P Hegde
Journal:  J Immunol Res       Date:  2017-12-14       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.